Cargando…
Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
BACKGROUND: The performance of live attenuated Japanese Encephalitis SA 14-14-2 vaccine (CD-JEV) among children previously given inactivated mouse brain-derived JE vaccine (IMBV) is unknown. We evaluated the safety and immunogenicity of CD-JEV administered to 2- and 5-year-old children in Sri Lanka....
Autores principales: | Wijesinghe, Pushpa Ranjan, Abeysinghe, M.R. Nihal, Yoksan, Sutee, Yao, Yafu, Zhou, Benli, Zhang, Lei, Fleming, Jessica A., Marfin, Anthony A., Victor, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104688/ https://www.ncbi.nlm.nih.gov/pubmed/27773472 http://dx.doi.org/10.1016/j.vaccine.2016.10.028 |
Ejemplares similares
-
Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area
por: Turtle, Lance, et al.
Publicado: (2017) -
Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against
Circulating Heterologous JE Virus Genotypes
por: Erra, Elina O., et al.
Publicado: (2013) -
A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
por: Kim, Dong Soo, et al.
Publicado: (2014) -
A Single Dose of Vero Cell–Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain–Derived JE Vaccines
por: Erra, Elina O., et al.
Publicado: (2012) -
Immunopathology of Cutaneous Leishmaniasis in a Cohort of Sri Lankan
Patients
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2022)